Albumin dialysis with MARS for the treatment of anabolic steroid-induced cholestasis
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 6
Abstract
Background and aims. Steroid-related hepatotoxicity has become one of the most relevant causes of drug induced livercholestasis. Some patients do not improve after standard medical treatment (SMT) and may therefore require other approaches, like extracorporeal liver support. Material and methods. We report four cases of patients with pruritus, abnormal liver function tests and biopsy-proven anabolic steroid-induced cholestasis who were unresponsive to SMT. They underwent treatment with albumin dialysis (Molecular Adsorbent Recirculating System -MARS®-). A minimum of two MARS sessions were performed. Results. After MARS® procedure, patients' symptoms improved, as well as liver function tests, thus avoiding liver transplantation. Conclusion. Albumin dialysis appears as a valuable therapeutic option for the management of anabolic steroid-induced cholestasis in patients that are unresponsive to SMT.
Authors and Affiliations
Francia Díaz, Esteban Sáez-González, Salvador Benlloch, Diego Álvarez-Sotomayor, Isabel Conde, Begoña Polo, María García, Martín Prieto
Keywords
Related Articles
- EP ID EP207235
- DOI -
- Views 120
- Downloads 0
Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritis
Fibrosing cholestatic hepatitis (FCH) is an aggressive and usually fatal form of viral hepatitis in immunocompromised patients. It is characterized by progressive cholestasis leading to hepatic failure, and a characteris...
DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma
Introduction. Hypermethylation of relevant genes may affect the prognosis of patients with cancer. Thepurpose of this study was to analyze whether methylation of the promoter regions of cell cycle regulatorsas well as el...
Hepatic hydrothorax: Current concepts of pathophysiology and treatment options
Pleural effusions develop in 6-10% of patients with end-stage liver disease. Although, commonly seen in conjunction with ascites, isolated hepatic hydrothorax can occur in a small number of patients with cirrhosis. Refra...
Characteristics of hepatitis C treatment with pegylated interferons and ribavirin
The effect of interferon alfa against hepatitis C virus has been well documented. However, clinical efficacy is low due to the short interferon residence in the body. To prolong half-life, interferon molecules have been...
Predicting early discharge from hospital after liver transplantation (ERDALT) at a single center: a new model
Background & rationale. Limited information related to Liver Transplantation (LT) costs in South America exists. Additionally, costs analysis from developed countries may not provide comparable models for tho...